Protective Effect of Irisin on Atherosclerosis via Suppressing Oxidized Low Density Lipoprotein Induced Vascular Inflammation and Endothelial Dysfunction.
Irisin, a newly discovered myokine, is considered as a promising candidate for the treatment of metabolic disturbances and cardiovascular diseases. In the present study, we used two animal models, apolipoprotein E-deficient mice fed on a high-cholesterol diet and a mouse carotid partial ligation mod...
Main Authors: | Yuzhu Zhang, Qian Mu, Zheng Zhou, Haibo Song, Yuan Zhang, Fei Wu, Miao Jiang, Fang Wang, Wen Zhang, Liang Li, Lei Shao, Xingli Wang, Shiwu Li, Lijun Yang, Qi Wu, Mingxiang Zhang, Dongqi Tang |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4927070?pdf=render |
Similar Items
-
Irisin Inhibits Atherosclerosis by Promoting Endothelial Proliferation Through microRNA126‐5p
by: Yuzhu Zhang, et al.
Published: (2016-09-01) -
Irisin promotes human umbilical vein endothelial cell proliferation through the ERK signaling pathway and partly suppresses high glucose-induced apoptosis.
by: Haibo Song, et al.
Published: (2014-01-01) -
Irisin Induces Angiogenesis in Human Umbilical Vein Endothelial Cells In Vitro and in Zebrafish Embryos In Vivo via Activation of the ERK Signaling Pathway.
by: Fei Wu, et al.
Published: (2015-01-01) -
Endothelial Transcytosis of Lipoproteins in Atherosclerosis
by: Xinbo Zhang, et al.
Published: (2018-09-01) -
Serum Irisin Levels, Endothelial Dysfunction, and Inflammation in Pediatric Patients with Type 2 Diabetes Mellitus and Metabolic Syndrome
by: Anna S. Huerta-Delgado, et al.
Published: (2020-01-01)